Wednesday, May 20, 2026
S&P 500 · NVDA · BTC
Wealth · Field Notes

How Cascade Investment de-allocates from private LLMs — and what the rest of the street can’t see.

From inside the rooms where Cascade Investment de-allocates from private LLMs. Notes from operators, not analysts.

Editorial cover: How Cascade Investment de-allocates from private LLMs — and what the rest of the street can’t see

INTELAR · Editorial cover · Editorial visual for the Wealth desk.

What changed

For most of the past year, the consensus on Cascade Investment and discretionary research sat in a place that was easy to ignore. That ended the morning Cascade Investment began to reshape discretionary research in production. The discretion economy read it as incremental for about ninety minutes. Then the buyer calls started.

The functional change runs three layers deep: surface (what principals and CIOs at family offices see), interface (what their tools call), and pricing (what the CFO signs). All three moved in the same release. That is rare, and it is the reason the rollout took the market by surprise.

The evidence

The renewal cohort tells the cleanest story. Among principals and CIOs at family offices who renewed contracts with Cascade Investment in Q1, 84% expanded seat count, 71% added a second workload, and 58% retired at least one competing line item. Those are not adoption numbers. Those are consolidation numbers.

There is a temptation to read these numbers as a Cascade Investment story. They are also a category story. The discretion economy as a whole is consolidating around two or three primitives, and discretionary research is one of them. Cascade Investment happens to be the loudest mover. The next two are not far behind, and the gap to the long tail is widening.

The friction to try it is effectively zero. The friction to revert is high. That is the entire story.
By the numbers INTELAR data desk · Wealth · Field Notes
3.4–9.1×
Cost compression
vs prior external advisory
22→61%
Adoption shift
named-account share, 4-month window
−47%
Time-to-decision
pilot-to-contract median

Second-order effects

The buyer-side implication is sharper than the vendor-side one. principals and CIOs at family offices who deploy now lock in time-to-insight savings that compound across renewal cycles. principals and CIOs at family offices who wait twelve months will face the same vendor, the same prices, and a competitor who has already absorbed the operational learning curve.

The downstream effect to watch is on adjacent categories. Once Cascade Investment reshapes discretionary research at scale, the budget that previously sat with external advisory vendors becomes contestable. We expect at least two consolidation events in that adjacency over the next three quarters, with the named acquirers already public.

What to watch

What we will be watching at the desk between now and the next earnings cycle:

  • Internal eval framework releases. Cascade Investment publishing its own benchmark for discretionary research would be a confidence signal. Declining to publish is also a signal, in the other direction.
  • Cascade Investment's next pricing change. Watch whether discretionary research stays on the standard tier or migrates to an enterprise-only SKU. The first signals where the discretion economy thinks the demand floor is.
  • Whether the second mover ships a comparable discretionary research primitive within ninety days, or holds back to differentiate on governance. Both are signals, in opposite directions.
  • Renewal cohort behavior in Q3. If expansion rates hold above 80% and consolidation rates above 50%, the thesis here is intact. If either softens, re-underwrite.

Frequently asked

What does this mean for incumbents whose discretionary research business depends on the old model?
Either reprice or repackage. The incumbents who reprice within ninety days hold the renewal cohort. The ones who attempt to repackage without repricing lose the lower half of the install base within a year. Both outcomes are visible in prior category transitions.
Is there a defensible argument for waiting twelve months?
In regulated environments and capital-constrained teams, yes. Elsewhere, the wait is mostly an option value calculation against a market that is moving faster than the option premium pays. The math gets worse, not better, with delay.
What is the most common buyer mistake we see on this?
Treating discretionary research as a standalone purchase rather than a workflow layer. The single-vendor view underestimates the integration debt to existing external advisory systems. Buyers who run a workflow-level diligence land at a defensible total cost. Buyers who run a product-level diligence do not.

This is a moving picture, and the numbers will refresh by the next earnings cycle. The trade we keep flagging to principals and CIOs at family offices is the same one: do the workflow-level diligence now, not the product-level diligence later. The savings sit in the workflow.

More from Wealth →